Matches in SemOpenAlex for { <https://semopenalex.org/work/W2092859008> ?p ?o ?g. }
Showing items 1 to 88 of
88
with 100 items per page.
- W2092859008 endingPage "49" @default.
- W2092859008 startingPage "47" @default.
- W2092859008 abstract "Retinal and other tissue histamine synthesis is increased in experimental diabetes; histamine infusion causes blood-ocular barrier breakdown in nondiabetic rats. We have examined the hypothesis that antihistamines prevent blood-ocular barrier breakdown in streptozotocin diabetes using male Sprague-Dawley rats held 28 days. During the last 7 days they were divided into these treatment groups: control (C), untreated diabetic (D), diabetic rats receiving diphenhydramine-HCl (B), diabetic rats receiving ranitidine (R) and diabetic rats receiving diphenhydramine and ranitidine (BR). Vitreous albumin content was measured 6 hr following fluorescein isothiocyanate bovine serum albumin (FITCBSA) injection. Data show that D had a 98.3% increase in vitreous body FITCBSA over C (p less than 0.05) while B and R showed respective decreases of 34.9% and 51.4% compared to D, R being significantly lower than D (p less than 0.05). BR showed a decrease of 71% (p less than 0.05) compared to D, and R and BR groups were not significantly different from C (p less than 0.05). Leakage into the vitreous was from the retina, not the ciliary body. These data indicate that 1) experimental diabetes results in elevated blood-ocular barrier permeability, which can be reversed by diphenhydramine-HCl and ranitidine; and 2) histamine H1- and H2-receptor activation and interaction by altered endogenous histamine metabolism may mediate blood-ocular barrier breakdown, implicating a pathogenic role of histamine in diabetic retinopathy." @default.
- W2092859008 created "2016-06-24" @default.
- W2092859008 creator A5028170569 @default.
- W2092859008 creator A5038973231 @default.
- W2092859008 creator A5039416369 @default.
- W2092859008 creator A5061569416 @default.
- W2092859008 creator A5067112747 @default.
- W2092859008 creator A5071826474 @default.
- W2092859008 creator A5074028954 @default.
- W2092859008 creator A5085880979 @default.
- W2092859008 date "1988-01-01" @default.
- W2092859008 modified "2023-09-26" @default.
- W2092859008 title "Antihistamines reverse blood-ocular barrier breakdown in experimental diabetes" @default.
- W2092859008 cites W1546955364 @default.
- W2092859008 cites W1968170469 @default.
- W2092859008 cites W2042540070 @default.
- W2092859008 cites W2062337820 @default.
- W2092859008 cites W2081164673 @default.
- W2092859008 cites W2121784482 @default.
- W2092859008 cites W2129179416 @default.
- W2092859008 cites W2162878421 @default.
- W2092859008 cites W2178045990 @default.
- W2092859008 cites W4248896202 @default.
- W2092859008 doi "https://doi.org/10.1016/0891-6632(88)90029-3" @default.
- W2092859008 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/2898479" @default.
- W2092859008 hasPublicationYear "1988" @default.
- W2092859008 type Work @default.
- W2092859008 sameAs 2092859008 @default.
- W2092859008 citedByCount "18" @default.
- W2092859008 countsByYear W20928590082016 @default.
- W2092859008 countsByYear W20928590082019 @default.
- W2092859008 crossrefType "journal-article" @default.
- W2092859008 hasAuthorship W2092859008A5028170569 @default.
- W2092859008 hasAuthorship W2092859008A5038973231 @default.
- W2092859008 hasAuthorship W2092859008A5039416369 @default.
- W2092859008 hasAuthorship W2092859008A5061569416 @default.
- W2092859008 hasAuthorship W2092859008A5067112747 @default.
- W2092859008 hasAuthorship W2092859008A5071826474 @default.
- W2092859008 hasAuthorship W2092859008A5074028954 @default.
- W2092859008 hasAuthorship W2092859008A5085880979 @default.
- W2092859008 hasConcept C1122143 @default.
- W2092859008 hasConcept C113045295 @default.
- W2092859008 hasConcept C126322002 @default.
- W2092859008 hasConcept C134018914 @default.
- W2092859008 hasConcept C2776125364 @default.
- W2092859008 hasConcept C2778371105 @default.
- W2092859008 hasConcept C2779280383 @default.
- W2092859008 hasConcept C2779829184 @default.
- W2092859008 hasConcept C2780719153 @default.
- W2092859008 hasConcept C2781292560 @default.
- W2092859008 hasConcept C555293320 @default.
- W2092859008 hasConcept C71924100 @default.
- W2092859008 hasConcept C98274493 @default.
- W2092859008 hasConceptScore W2092859008C1122143 @default.
- W2092859008 hasConceptScore W2092859008C113045295 @default.
- W2092859008 hasConceptScore W2092859008C126322002 @default.
- W2092859008 hasConceptScore W2092859008C134018914 @default.
- W2092859008 hasConceptScore W2092859008C2776125364 @default.
- W2092859008 hasConceptScore W2092859008C2778371105 @default.
- W2092859008 hasConceptScore W2092859008C2779280383 @default.
- W2092859008 hasConceptScore W2092859008C2779829184 @default.
- W2092859008 hasConceptScore W2092859008C2780719153 @default.
- W2092859008 hasConceptScore W2092859008C2781292560 @default.
- W2092859008 hasConceptScore W2092859008C555293320 @default.
- W2092859008 hasConceptScore W2092859008C71924100 @default.
- W2092859008 hasConceptScore W2092859008C98274493 @default.
- W2092859008 hasIssue "1" @default.
- W2092859008 hasLocation W20928590081 @default.
- W2092859008 hasLocation W20928590082 @default.
- W2092859008 hasOpenAccess W2092859008 @default.
- W2092859008 hasPrimaryLocation W20928590081 @default.
- W2092859008 hasRelatedWork W146812676 @default.
- W2092859008 hasRelatedWork W1982694306 @default.
- W2092859008 hasRelatedWork W2005432427 @default.
- W2092859008 hasRelatedWork W2013263241 @default.
- W2092859008 hasRelatedWork W2092859008 @default.
- W2092859008 hasRelatedWork W2125565819 @default.
- W2092859008 hasRelatedWork W2139776675 @default.
- W2092859008 hasRelatedWork W2384143444 @default.
- W2092859008 hasRelatedWork W2396622926 @default.
- W2092859008 hasRelatedWork W4248524990 @default.
- W2092859008 hasVolume "2" @default.
- W2092859008 isParatext "false" @default.
- W2092859008 isRetracted "false" @default.
- W2092859008 magId "2092859008" @default.
- W2092859008 workType "article" @default.